Literature DB >> 26083016

Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups.

Yijing He1,2,3,4, Janelle M Hoskins5, Scott Clark5, Nathan H Campbell5, Kim Wagner5, Alison A Motsinger-Reif2,3,6, Howard L McLeod1,2,3,4.   

Abstract

AIM: To evaluate the potential usefulness of selected SNPs to predict specific HLA alleles that are associated with drug-induced hypersensitivity reactions (HSR) in different ethnic groups. METHODS &
RESULTS: Five specific HLA alleles known to predict HSR were tagged by seven SNPs (rs1061235-HLA-A*31:01; rs2395029-HLA-B*57:01; rs3909184-HLA-B*15:02; rs9469003-HLA-B*58:01; rs3117583-HLA-B*58:01; rs9270986-HLA-DQA1*01:02 and rs3129900-HLA-DQA1*01:02). DNA from 24 African-Americans, 56 Asian, 44 Caucasians and 36 Hispanics of known high resolution HLA-A, B and DQA1 status were genotyped for tagSNPs using TaqMan. Sensitivity and specificity were considered the primary end points and were 100% across the four populations for rs2395029-HLA-B*57:01. SNP prediction of HLA-A*31:01 had 100% sensitivity and 84% specificity.
CONCLUSION: This study demonstrates the utility of SNP tagging as a 'real time' approach to predict or exclude the presence of specific HLA alleles of known importance to HSR across diverse ethnic groups. Original submitted 24 April 2014; Revision submitted 2 April 2015.

Entities:  

Keywords:  HLA; drug-induced hypersensitivity; human leukocyte antigen; pharmacogenetics; pharmacogenomics; risk mitigation

Mesh:

Substances:

Year:  2015        PMID: 26083016     DOI: 10.2217/pgs.15.41

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  6 in total

1.  Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Authors:  Ann M Moyer; Manish J Gandhi
Journal:  Methods Mol Biol       Date:  2022

2.  Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds.

Authors:  Amanda Buchner; Xiuying Hu; Katherine J Aitchison
Journal:  Front Pharmacol       Date:  2021-07-26       Impact factor: 5.988

3.  Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations.

Authors:  Vanessa Câmara Fernandes; Marco Antônio M Pretti; Luiza Tamie Tsuneto; Maria Luiza Petzl-Erler; Guilherme Suarez-Kurtz
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.810

Review 4.  Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes.

Authors:  Willy Albert Flegel; Kshitij Srivastava; Tristan Michael Sissung; Barry Ronald Goldspiel; William Douglas Figg
Journal:  Vox Sang       Date:  2020-09-30       Impact factor: 2.996

Review 5.  Developing pharmacogenetic screening methods for an emergent country: Vietnam.

Authors:  Dinh Van Nguyen; Christopher Vidal; Hieu Chi Chu; Sheryl van Nunen
Journal:  World Allergy Organ J       Date:  2019-06-06       Impact factor: 4.084

6.  A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.

Authors:  Gurpreet S Ghattaoraya; Yenal Dundar; Faviel F González-Galarza; Maria Helena Thomaz Maia; Eduardo José Melo Santos; Andréa Luciana Soares da Silva; Antony McCabe; Derek Middleton; Ana Alfirevic; Rumona Dickson; Andrew R Jones
Journal:  Database (Oxford)       Date:  2016-05-17       Impact factor: 3.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.